Comprehensive Stock Analysis of Syneos Health, Inc.(NASDAQ:SYNH): Meta Financial Group, Inc.(NASDAQ:CASH)

0
9

Syneos Health, Inc. (SYNH) will report its next earnings on Mar 18 AMC. The company reported the earnings of $0.95/Share in the last quarter where the estimated EPS by analysts was $0.81/share. The difference between the expected and actual EPS was $0.14/share, which represents an Earnings surprise of 17.3%.

Many analysts are providing their Estimated Earnings analysis for Syneos Health, Inc. and for the current quarter 13 analysts have projected that the stock could give an Average Earnings estimate of $0.61/share. These analysts have also projected a Low Estimate of $0.59/share and a High Estimate of $0.65/share.

In case of Revenue Estimates, 13 analysts have provided their consensus Average Revenue Estimates for Syneos Health, Inc. as 1.12 Billion. According to these analysts, the Low Revenue Estimate for Syneos Health, Inc. is 1.11 Billion and the High Revenue Estimate is 1.12 Billion. The company had Year Ago Sales of 1.06 Billion.

These analysts also forecasted Growth Estimates for the Current Quarter for SYNH to be 9.1%. They are projecting Next Quarter growth of 14.52%. For the next 5 years, Syneos Health, Inc. is expecting Growth of 15.57% per annum, whereas in the past 5 years the growth was 8.71% per annum.

Some buy side analysts are also providing their Analysis on Syneos Health, Inc., where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 2 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Syneos Health, Inc. might touch $65 high while the Average Price Target and Low price Target is $56.62 and $44 respectively.

Syneos Health, Inc. closed its last trading session at $50.45 with the loss of -0.77%. The Market Capitalization of the company stands at 5.1 Billion. The Company has 52-week high of $56.34 and 52-week low of $36.26. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -1.51% where SMA50 and SMA200 are 0.66% and 4.07% respectively. The Company Touched its 52-Week High on 02/25/19 and 52-Week Low on 12/24/18.

The Relative Volume of the company is 0.47 and Average Volume (3 months) is 755.03 million. The company’s P/E (price to earnings) ratio is 245.39 and Forward P/E ratio of 13.9.

The company shows its Return on Assets (ROA) value of 0.3%. The Return on Equity (ROE) value stands at 0.9%. While it’s Return on Investment (ROI) value is 2.1%.

While looking at the Stock’s Performance, Syneos Health, Inc. currently shows a Weekly Performance of -4.03%, where Monthly Performance is 20.34%, Quarterly performance is 5.5%, 6 Months performance is 9.71% and yearly performance percentage is 33.14%. Year to Date performance value (YTD perf) value is 27.22%. The Stock currently has a Weekly Volatility of 2.62% and Monthly Volatility of 3.43%.

Meta Financial Group, Inc. (CASH) will report its next earnings on Apr 29 AMC. The company reported the earnings of $0.39/Share in the last quarter where the estimated EPS by analysts was $0.4/share. The difference between the expected and actual EPS was $-0.01/share, which represents an Earnings surprise of -2.5%.

Many analysts are providing their Estimated Earnings analysis for Meta Financial Group, Inc. and for the current quarter 4 analysts have projected that the stock could give an Average Earnings estimate of $0.87/share. These analysts have also projected a Low Estimate of $0.54/share and a High Estimate of $1.13/share.

In case of Revenue Estimates, 3 analysts have provided their consensus Average Revenue Estimates for Meta Financial Group, Inc. as 172.83 Million. According to these analysts, the Low Revenue Estimate for Meta Financial Group, Inc. is 166.9 Million and the High Revenue Estimate is 176.8 Million. The company had Year Ago Sales of 124.82 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for CASH to be -32%. They are projecting Next Quarter growth of 70.59%. For the next 5 years, Meta Financial Group, Inc. is expecting Growth of 44.44% per annum, whereas in the past 5 years the growth was -16.73% per annum.

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Meta Financial Group, Inc. might touch $36 high while the Average Price Target and Low price Target is $31 and $25 respectively.

Meta Financial Group, Inc. closed its last trading session at $21.2 with the gain of 3.07%. The Market Capitalization of the company stands at 848.44 Million. The Company has 52-week high of $38.87 and 52-week low of $17.84. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 8.55% where SMA50 and SMA200 are -0.06% and -12.75% respectively. The Company Touched its 52-Week High on 06/05/18 and 52-Week Low on 03/25/19.

The Relative Volume of the company is 0.53 and Average Volume (3 months) is 397.25 million. The company’s P/E (price to earnings) ratio is 11.62 and Forward P/E ratio of 6.39.

The company shows its Return on Assets (ROA) value of 1.2%. The Return on Equity (ROE) value stands at 10.4%. While it’s Return on Investment (ROI) value is 11.6%.

While looking at the Stock’s Performance, Meta Financial Group, Inc. currently shows a Weekly Performance of 2.82%, where Monthly Performance is 6.48%, Quarterly performance is 2.39%, 6 Months performance is -19.85% and yearly performance percentage is -42.32%. Year to Date performance value (YTD perf) value is 12.69%. The Stock currently has a Weekly Volatility of 2.36% and Monthly Volatility of 3.22%.

SHARE